Gaurav Gulati, M.D., M.Sc., M.B.A.

Gaurav Gulati, M.D., M.Sc., M.B.A.

Associate Chief Medical Officer, Ambulatory Specialties

Gaurav Gulati, M.D., M.Sc., M.B.A., Associate Chief Medical Officer, Ambulatory Specialties

Gulati is a practicing rheumatologist, associate clinical professor for the UC Davis School of Medicine, and Associate Chief Medical Officer for Ambulatory Specialties at UC Davis Health.

In his role, Gulati oversees clinical operations and strategic growth across 20 medical specialties spanning all ambulatory sites. In collaboration with clinical medical directors, he focuses on aligning specialty care delivery with institutional goals, enhancing operational performance, and expanding access to high-quality, patient-centered services.

Gulati earned a Master of Business Administration in health care administration and finance from the University of Cincinnati, a Master of Science in clinical and translational research, and graduated from the Maulana Azad Medical College, University of Delhi.

Gulati has earned numerous awards and honors, such as the UC Davis Health Chief of Staff Award for exemplary leadership, Diamond Doc Award, and recognition by Cincinnati Magazine as a "Top Doctor." He is actively involved in various committees and workgroups to help advance health care systems and patient care delivery.

Gulati’s commitment to gender equality, diversity, and inclusion is reflected in his efforts to develop inclusive systems within the health care environment. His servant leadership and outcomes-focused initiatives have made a significant impact on the medical community, both regionally and nationally.

Gulati's leadership is characterized by his commitment to systems management and growth, academic and health care administration, quality and process improvement, and excellence in medical education.

In addition to his clinical and administrative accomplishments, Gulati is a respected educator and researcher. He has delivered numerous talks and lectures on topics related to systemic lupus erythematosus, rheumatoid arthritis, and health care management. His research has focused on innovative approaches to disease management and improving patient outcomes.